Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Rodman David Malcom sold 14,474 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Jun 15 to Jun 17, 2026 · Filed Jun 17, 2026
From Jun 15 to Jun 17, 2026, Rodman David Malcom (Chief Medical Officer) sold 14,474 Mineralys Therapeutics, Inc. shares at an average US$24.19 for US$350K under a trading plan, leaving 57,095 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 14,474 shares
- Price
- US$24.19 average (US$23.81 to US$25.00)
- Value
- US$350K
- Holding after
- 57,095 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 3,542 | US$10.20 | 66,985 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 9,890 | US$23.81 | 57,095 | Direct |
| Jun 17, 2026 | Common Stock | Option exercise | 4,167 | US$14.25 | 61,262 | Direct |
| Jun 17, 2026 | Common Stock | Option exercise | 417 | US$15.44 | 61,679 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 4,584 | US$25.00 | 57,095 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Rodman David Malcom
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Rodman David Malcom · Aug 12, 2026
- Form 4 · Rodman David Malcom · Jul 20, 2026
- Form 4 · Rodman David Malcom · Jul 15, 2026
- Form 4 · Rodman David Malcom · Jul 10, 2026
- Form 4 · Rodman David Malcom · Jun 12, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026